207_Combined course Presentations

NHL: A Heterogeneous Disease

PMLBCL (2%)

 75% of aggressive NHL  40%: localized disease  40-50%: extranodal disease

ALCL

MCL (6%)

Burkitt’s

DLBCL (31%)

Other

CLL/SLL (6%)

FL (22%)

MALT/Nodal MZL (10%)